Shoreline, WA, United States of America

Joyoti Dey

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Joyoti Dey: Innovator in Cancer Treatment

Introduction

Joyoti Dey is a prominent inventor based in Shoreline, WA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical combinations. With a total of 3 patents to her name, Dey is recognized for her dedication to improving therapeutic options for patients battling cancer.

Latest Patents

Dey's latest patents focus on combination therapies for the treatment of various cancers, including leukemia, lymphoma, and triple-negative breast cancer. The disclosures provide detailed methodologies for utilizing CDK inhibitors, alongside BCL-2 inhibitors or proteasome inhibitors, to enhance treatment efficacy. These innovative combinations aim to offer new hope for patients facing challenging cancer diagnoses.

Career Highlights

Throughout her career, Joyoti Dey has been associated with Presage Biosciences, Inc., where she has played a crucial role in advancing cancer treatment research. Her work has not only contributed to the scientific community but has also paved the way for potential breakthroughs in clinical applications.

Collaborations

Dey collaborates with Richard Klinghoffer, who is also involved in the research and development of cancer therapies. Their partnership exemplifies the importance of teamwork in the pursuit of innovative solutions in the medical field.

Conclusion

Joyoti Dey's contributions to cancer treatment through her patented innovations highlight her commitment to improving patient outcomes. Her work continues to inspire advancements in the pharmaceutical industry, making a significant impact on the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…